Currently own, or are looking to buy a used Ford? Read on to learn everything you need to know about the infamous Ecoboost ...

Even the least reliable carmakers are gaining ground on the perennial reliability leaders, Toyota and Honda. Volvo has made the most dramatic improvement over the past decade, but almost all ...

The 2026 GMC Acadia is a comfortable and powerful midsize SUV with engaging driving dynamics. Pricing for the 2026 Acadia starts at $45,795, and it is available in four different trims. GMC boasted ...

For 2026, GMC introduces the Acadia Denali Ultimate trim level. It adds special “Woodland Mahogany” leather upholstery and “Paldao” wood trim, both festooned with topographical markings of Denali (the ...

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Acadia Healthcare Company ...

FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced that Debra K. Osteen, former Board member and former Chief Executive ...

The GMC Acadia, a cornerstone of the brand’s crossover lineup, now finds itself in a challenging position. Consumer Reports (CR) has stripped the three-row SUV of its coveted “Recommended” rating for ...

Acadia Healthcare faces foundational challenges: rising legal, insurance, and compliance costs and a Medicaid-heavy payer mix under policy pressure. ACHC’s aggressive capex strategy has led to poor ...

Neurological biotech Acadia Pharmaceuticals recently rolled out a rebrand as it seeks to expand further into the rare disease space. As is the case with most life sciences companies these days, AI ...

Both Acadia Pharmaceuticals and e-therapeutics pulled back the curtain this week on new looks for their respective corporate brand identities. E-therapeutics was the more drastic makeover of the two.

You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. An error has occurred. Please try again ...

Acadia Pharmaceuticals Inc. is downgraded from Buy to Hold following the failure of its carbetocin (ACP-101) program for Prader-Willi Syndrome. Despite the setback, ACAD remains positioned for growth ...